This inventor holds 1 USPTO granted patent. Top assignee: Helix Biopharma Corporation. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: Don Segal: Innovator in Cancer Treatment
Introduction
Don Segal is a notable inventor based in Stouffville, Canada. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on methods and compositions that inhibit cancer cell growth, showcasing his commitment to advancing medical science.
Latest Patents
Don Segal holds a patent for a "Method and composition for inhibiting cancer cell growth." This pharmaceutical composition is designed to inhibit the growth of cancer cells in a mammalian subject. The composition includes a urease enzyme, along with a chemical entity that enhances the delivery of the enzyme to cancer cells when administered. Additionally, the patent outlines methods for enhancing the effectiveness of weakly basic anti-tumor compounds, assessing the presence, size, or condition of solid tumors, and a gene therapy composition for treating cancer.
Career Highlights
Throughout his career, Don Segal has been dedicated to developing innovative solutions for cancer treatment. His work has the potential to improve the lives of many patients facing this challenging disease. He is associated with Helix Biopharma Corporation, where he continues to contribute to groundbreaking research.
Collaborations
Don Segal has collaborated with notable colleagues, including Jerry McElroy and John M Docherty. These partnerships have fostered a collaborative environment that enhances the development of effective cancer treatments.
Conclusion
Don Segal's contributions to cancer research and treatment exemplify the impact of innovation in medicine. His patent and ongoing work at Helix Biopharma Corporation highlight his dedication to improving patient outcomes. Through his efforts, he continues to pave the way for advancements in cancer therapy.